ArticleFrontiers in oncology2024

Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus.

Emad Dawoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.